Search - tctmd.com

Displaying 81 - 96 of 96

Sort: Relevancy | Date

News Daily News

PCI with Concomitant Aortic Stenosis May Not Increase Short-term Mortality

L.A. McKeown

March 23, 2012

News Daily News

Study Focuses on Systemic Inflammation After TAVR

Caitlin E. Cox

March 07, 2012

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

News Industry News

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

November 09, 2011

News Conference News

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

November 09, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Conference News

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

November 07, 2011

News Industry News

FDA approves first artificial aortic heart valve placed without open-heart surgery

November 02, 2011

News Daily News

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

October 06, 2011

News Daily News

FDA Panel Recommends Approval of Transcatheter Heart Valve

July 21, 2011

News Daily News

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

May 09, 2011

News Daily News

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

L.A. McKeown

May 06, 2011

News Daily News

AHA Statement Recommends Cardiac Cath Options for Pediatric Conditions

Jason Kahn

May 02, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Daily News

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

L.A. McKeown

January 13, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

Caitlin E. Cox

January 11, 2011

Advertisement

PCI with Concomitant Aortic Stenosis May Not Increase Short-term Mortality

Study Focuses on Systemic Inflammation After TAVR

Societies Recommend TAVR Program Requirements

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

FDA approves first artificial aortic heart valve placed without open-heart surgery

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

FDA Panel Recommends Approval of Transcatheter Heart Valve

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

AHA Statement Recommends Cardiac Cath Options for Pediatric Conditions

PARTNER: TAVI Cost Effective Compared With Standard Care

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

NEJM Letters Take on PARTNER Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content